Results 81 to 90 of about 268,406 (174)

Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer. [PDF]

Support Care Cancer, 2023
Aapro MS, Chaplin S, Cornes P, Howe S, Link H, Koptelova N, Mehl A, Di Palma M, Schroader BK, Terkola R.   +9 more
europepmc   +1 more source

Impact of treatment experience on patient knowledge of colony-stimulating factors among patients receiving cancer chemotherapy: evidence from S1415CD-a large pragmatic trial. [PDF]

Support Care Cancer, 2023
Lyman GH, Bansal A, Sullivan SD, Arnold KB, Barlow WE, Hershman DL, Lad TE, Ramsey SD.   +7 more
europepmc   +1 more source

p-ERK1/2 is a predictive factor of response to erythropoiesis-stimulating agents in low/int-1 myelodysplastic syndromes

Haematologica, 2010
Serum erythropoietin level less than 100U/L and a transfusion requirement of less than 2 units per month are the best predictive factors for response to treatment by erythropoiesis-stimulating agents in low/int-1 myelodysplastic syndromes. To investigate
Emilie Frisan, Patrycja Pawlikowska, Cecile Pierre-Eugène, Vivian Viallon, Laure Gibault, Sophie Park, Patrick Mayeux, François Dreyfus, Françoise Porteu, Michaëla Fontenay   +9 more
doaj   +1 more source

Colony stimulating factors in the nervous system. [PDF]

Semin Immunol, 2021
Chitu V, Biundo F, Stanley ER.
europepmc   +1 more source

Supportive therapies in the prevention of chemotherapy-induced febrile neutropenia and appropriate use of granulocyte colony-stimulating factors: a Delphi consensus statement. [PDF]

Support Care Cancer, 2022
Adamo V, Antonuzzo L, Danova M, De Laurentiis M, Marchetti P, Pinto C, Rosti G.   +6 more
europepmc   +1 more source

The Immune System [PDF]

, 1995
Modern biotherapy has been in use for some 30 years. The first types of biotherapy were nonspecific stimulators of the immune response, but advances in genetic engineering are allowing the mass production of pure biological products which are now being ...
Gallucci, Betty Bierut, McCarthy, Donna O.   +1 more
core   +1 more source

Continuous Intravenous Administration of Granulocyte-Colony-Stimulating Factors-A Breakthrough in the Treatment of Cancer Patients with Febrile Neutropenia. [PDF]

Medicina (Kaunas), 2021
Căinap C, Cetean-Gheorghe S, Pop LA, Leucuta DC, Piciu D, Mester A, Vlad C, Ovidiu C, Gherman A, Crişan C, Bereanu A, Bălăcescu O, Constantin AM, Dicu I, Bălăcescu L, Stan A, Achimaş-Cadariu P, Căinap S.   +17 more
europepmc   +1 more source

Colony-Stimulating Factors on Mobilizing CD34⁺ Cells and Improving Neurological Functions in Patients With Stroke: A Meta-Analysis and a Systematic Review. [PDF]

Front Pharmacol, 2021
Chen X, Sun W, Zhong P, Wu D.
europepmc   +1 more source

Clinical Outcomes of Secondary Prophylactic Granulocyte Colony-Stimulating Factors in Breast Cancer Patients at a Risk of Neutropenia with Doxorubicin and Cyclophosphamide-Based Chemotherapy. [PDF]

Pharmaceuticals (Basel), 2021
Choi JH, Geum MJ, Kang JE, Park NG, Oh YK, Rhie SJ.   +5 more
europepmc   +1 more source

Long-acting versus short-acting granulocyte colony-stimulating factors among cancer patients after chemotherapy in China: A systematic review and meta-analysis of randomized controlled trials. [PDF]

Medicine (Baltimore), 2021
Wang G, Zhang Y, Wang X, Sun Q, Xun Z, Yuan M, Li Z.   +6 more
europepmc   +1 more source